| Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study A Jaccard, N Gachard, B Marin, S Rogez, M Audrain, F Suarez, H Tilly, ... Blood, The Journal of the American Society of Hematology 117 (6), 1834-1839, 2011 | 411 | 2011 |
| CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe … D Leroux, F Mugneret, M Callanan, I Radford-Weiss, N Dastugue, ... Blood, The Journal of the American Society of Hematology 99 (11), 4154-4159, 2002 | 234 | 2002 |
| IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas N Gachard, M Parrens, I Soubeyran, B Petit, A Marfak, D Rizzo, M Devesa, ... Leukemia 27 (1), 183-189, 2013 | 217 | 2013 |
| L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature A Jaccard, B Petit, S Girault, F Suarez, R Gressin, JM Zini, V Coiteux, ... Annals of oncology 20 (1), 110-116, 2009 | 181 | 2009 |
| Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia F Nguyen-Khac, J Lambert, E Chapiro, A Grelier, S Mould, C Barin, ... Haematologica 98 (4), 649, 2013 | 142 | 2013 |
| The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal … A Renneville, N Boissel, N Gachard, D Naguib, C Bastard, S de Botton, ... Blood, The Journal of the American Society of Hematology 113 (21), 5090-5093, 2009 | 128 | 2009 |
| A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study P Chevallier, M Labopin, P Turlure, T Prebet, A Pigneux, M Hunault, ... Leukemia 25 (6), 939-944, 2011 | 125 | 2011 |
| Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older C Gardin, S Chevret, C Pautas, P Turlure, E Raffoux, X Thomas, ... Journal of clinical oncology 31 (3), 321-327, 2013 | 95 | 2013 |
| Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course N Put, K Van Roosbroeck, P Konings, P Meeus, C Brusselmans, K Rack, ... Annals of Hematology 91, 863-873, 2012 | 83 | 2012 |
| Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia M Lafage-Pochitaloff, L Baranger, M Hunault, W Cuccuini, C Lefebvre, ... Blood, The Journal of the American Society of Hematology 130 (16), 1832-1844, 2017 | 70 | 2017 |
| Outcome of older patients with acute myeloid leukemia in first relapse C Sarkozy, C Gardin, N Gachard, F Merabet, P Turlure, JV Malfuson, ... American journal of hematology 88 (9), 758-764, 2013 | 67 | 2013 |
| Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents I Youlyouz-Marfak, N Gachard, C Le Clorennec, I Najjar, F Baran-Marszak, ... Cell Death & Differentiation 15 (2), 376-385, 2008 | 65 | 2008 |
| GELA and GOELAMS Intergroup. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell … A Jaccard, N Gachard, B Marin, S Rogez, M Audrain, F Suarez, H Tilly, ... Blood 117 (6), 1834-9, 2011 | 60 | 2011 |
| Neurofibromatosis‐1 gene deletions and mutations in de novo adult acute myeloid leukemia E Boudry‐Labis, C Roche‐Lestienne, O Nibourel, N Boissel, C Terre, ... American journal of hematology 88 (4), 306-311, 2013 | 55 | 2013 |
| Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias L Couronne, E Lippert, J Andrieux, O Kosmider, I Radford-Weiss, ... Leukemia 24 (1), 201-203, 2010 | 55 | 2010 |
| Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method N Gachard, A Salviat, C Boutet, C Arnoulet, F Durrieu, B Lenormand, ... haematologica 93 (2), 215-223, 2008 | 52 | 2008 |
| Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup B Petit, MP Chaury, C Le Clorennec, A Jaccard, N Gachard, ... haematologica 90 (2), 200-206, 2005 | 48 | 2005 |
| PICALM–MLLT10 acute myeloid leukemia: A French cohort of 18 patients C Borel, N Dastugue, V Cances-Lauwers, MJ Mozziconacci, T Prebet, ... Leukemia research 36 (11), 1365-1369, 2012 | 44 | 2012 |
| Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy E Lippert, G Etienne, MJ Mozziconacci, S Laibe, C Gervais, S Girault, ... haematologica 95 (9), 1604, 2010 | 41 | 2010 |
| 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma A Cosson, E Chapiro, N Belhouachi, HA Cung, B Keren, F Damm, ... Genes, Chromosomes and Cancer 53 (8), 657-666, 2014 | 37 | 2014 |
